Global profiling of gene expression in cancer using genomics and proteomics

Current Opinion in Molecular Therapeutics

Volumn 3, Issue 6, 2001, Pages 538-545

  Hanash, S M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Gene expression profiling; Genomics; Mass spectrometry; Microarrays; Proteomics

Indexed keywords

ANTINEOPLASTIC AGENT; CALGRANULIN; COMPLEMENTARY DNA; MESSENGER RNA; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; SERINE PROTEINASE; TRASTUZUMAB; TUMOR MARKER;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; ASTROCYTOMA; B CELL LYMPHOMA; BREAST CANCER; BREAST CARCINOMA; CANCER GENETICS; CANCER INVASION; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; DNA LIBRARY; DNA MICROARRAY; ESOPHAGUS CANCER; GENE EXPRESSION PROFILING; GENE TECHNOLOGY; GENETIC TRANSCRIPTION; HUMAN; LIQUID CHROMATOGRAPHY; LUNG CANCER; MOUTH CARCINOMA; ONCOGENE NEU; PHAGE DISPLAY; PREDICTION; PROSTATE CANCER; PROTEOMICS; REVERSED PHASE LIQUID CHROMATOGRAPHY; RNA TRANSLATION; SQUAMOUS CELL CARCINOMA;

GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOME;

EID: 0035676770     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Use of laser capture microdissection, cDNA microarrays, and tissue microarrays in advancing our understanding of prostate cancer
2. Laser capture microdissection
3. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
4. Molecular portraits of human breast tumours
5. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
6. Molecular profiling of breast cancer: Portraits but not physiognomy
7. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns
8. Delineation of prognostic biomarkers in prostate cancer
9. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles
10. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis
11. Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles
12. Gene expression analysis as an aid to the identification of drug targets
13. Biomedical applications of two-dimensional electrophoresis using immobilized pH gradients: Current status
14. Mass spectrometry and proteomics
15. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
16. Membrane proteomics: Use of additive main effects with multiplicative interaction model to classify plasma membrane proteins according to their solubility and electrophoretic properties
17. Mass spectrometric characterization of proteins extracted from Jurkat T-cell detergent-resistant membrane domains
18. Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues
19. A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library
20. Protein microarrays for gene expression and antibody screening
21. Analysis of yeast protein kinases using protein chips
22. Antibody arrays for high-throughput screening of antibody-antigen interactions
23. UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions
24. An array immunosensor for simultaneous detection of clinical analytes
25. High-throughput microarray-based enzyme-linked immunosorbent assay (ELISA)
26. Mass-sensing, multianalyte microarray immunoassay with imaging detection
27. Protein microchips: Use for immunoassay and enzymatic reactions
28. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions
29. Printing proteins as microarrays for high-throughput function determination
30. Inaugural article: Immunoassays with rolling circle DNA amplification: A versatile platform for ultrasensitive antigen detection
31. Tissue microarrays for high-throughput molecular profiling of tumor specimens
32. Tissue microarray technology for high-throughput molecular profiling of cancer
33. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front
34. Protein based microarrays: A tool for probing the proteome of cancer cells and tissues
35. Lineage-related polypeptide markers in acute lymphoblastic leukemia detected by two-dimensional electrophoresis
36. A database of protein expression in lung cancer
37. Identification of gel-separated tumor marker proteins by mass spectrometry
38. Detection of polypeptides associated with the histopathological differentiation of primary lung carcinoma
39. Lung tumor cells: A multivariate approach to cell classification using two-dimensional protein pattern
40. Highly resolving two-dimensional gels for protein sequencing
41. Phorbol 12-myristate 13-acetate-induced phosphorylation of Op18 in Jurkat T-cells. Identification of phosphorylation sites by matrix-assisted laser desorption ionization mass spectrometry
42. Characterization of the gene for a proliferation related phosphoprotein (oncoprotein 18) expressed in high amounts in acute leukemia
43. Molecular cloning of a novel human leukemia associated gene: Evidence of conservation in animal species
44. Identification of a polypeptide associated with the malignant phenotype in acute leukemia
45. Proteomic profiling of the cancer microenvironment by antibody arrays
46. Profiling proteins from azoxymethane-induced colon tumors at the molecular level by matrix-assisted laser desorption/ionization mass spectrometry
47. Computational analysis of microarray data
48. Analysis of variance for gene expression microarray data
49. Whole-genome expression analysis: Challenges beyond clustering
50. Knowledge-based analysis of microarray gene expression data by using support vector machines
51. Support vector machine classification and validation of cancer tissue samples using microarray expression data